Development of a physiologically based pharmacokinetic model for volatile fractions of gasoline using chemical lumping analysis

Environmental Science and Technology

Volumn 38, Issue 21, 2004, Pages 5674-5681

  Dennison, James E ^a   Andersen, Melvin E ^b   Clewell, Harvey J ^c   Yang, Raymond S H ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^c ENVIRON INTERNATIONAL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORPTION; CHEMICAL ANALYSIS; CHEMICAL ENGINEERING; GASOLINE; HYDROCARBONS; MATHEMATICAL MODELS; METABOLISM; MIXTURES;

CHEMICAL LUMPING; GASOLINE HYDROCARBONS; PHYSIOLOGICALLY BASED PHARMOKINETIC (PBPK);

PHARMACOKINETICS;

CHEMICAL COMPOUND; GASOLINE;

CHEMICAL ANALYSIS;

AIR CONDITIONING; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; CHEMICAL LUMPING ANALYSIS; EVAPORATION; EXPOSURE; INHIBITION KINETICS; METABOLIC INHIBITION; METABOLISM; MODEL; PARAMETER;

ADSORPTION; ANIMALS; BENZENE DERIVATIVES; GASOLINE; HEXANES; MODELS, BIOLOGICAL; RATS; TISSUE DISTRIBUTION; TOLUENE; VOLATILIZATION; XYLENES;

ANIMALIA;

EID: 7444239735     PISSN: 0013936X     EISSN: None     Source Type: Journal    
DOI: 10.1021/es035201s     Document Type: Article

References (45)

1. Dement, J. M.; Hensley, L.; Gitelman, A. Carcinogenicity of gasoline: a review of epidemiological evidence. Ann. N. Y. Acad. Sci. 1997, 837, 53-76.
2. INEGI. National Institute of Statistics, Geography and Informatics, Gasoline production volume, by selected countries, 1995-1999. 2002, http://www.inegi.gob.mx/estadistica/ingles/economia/internacional/ine_10.html.
3. NIOSH, Mixed Exposures. 1999, http://www.cdc.gov/niosh/psmixed.html.
4. Wixtrom, R. N.; Brown, S. L. Individual and population exposures to gasoline. J. Expo. Anal. Environ. Epidemiol. 1992, 2, 23-78.
5. Hakkola, M.; Saarinen, L. Exposure of tanker drivers to gasoline and some of its components. Ann. Occup. Hyg. 1996, 40, 1-10.
6. Hakkola, M. A.; Saarinen, L. H. Customer exposure to gasoline vapors during refueling at service stations. Appl. Occup. Environ. Hyg. 2000, 15, 677-680.
7. Laitinen, J.; Kangas, J.; Pekari, K.; Liesivuori, J. Short-time exposure to benzene and gasoline at garages. Chemosphere 1994, 28, 197-205.
8. IARC. IARC Monographs Programme on the Evaluation of Carcinogenic Risks to Humans; 2002.
9. Graham, D. G.; Amarnath, V.; Valentine, W. M.; Pyle, S. J.; Anthony, D. C. Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit. Rev. Toxicol. 1995, 25, 91-112.
10. OEHHA. Public Health Goal for Ethylbenzene In Drinking Water; Office of Environmental Health Hazard Assessment, CalEPA: 1997; pp 1-27.
11. OEHHA. Public Health Goal for Xylene In Drinking Water; Office of Environmental Health Hazard Assessment, CalEPA: 1997; pp 1-21.
12. OEHHA. Public Health Goal for Toluene In Drinking Water; Office of Environmental Health Hazard Assessment, CalEPA: 1999; pp 1-37.
13. Andersen, M. E. Physiological modelling of organic compounds. Ann. Occup. Hyg. 1991, 35, 309-322.
14. Filser, J. G.; Johanson, G.; Kessler, W.; Kreuzer, P. E.; Stei, P.; Baur, C.; Csanady, G. A. A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. IARC Scientific Publications (Lyon) 1993, 127, 65-78.
15. Fisher, J. W.; Gargas, M. L.; Allen, B. C.; Andersen, M. E. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol. Appl. Pharmacol. 1991, 109, 183-195.
16. Paterson, S.; Mackay, D. A pharmacokinetic model of styrene inhalation with the fugacity approach. Toxicol. Appl. Pharmacol. 1986, 82, 444-453.
17. Georgopoulos, P. G.; Walia, A.; Roy, A.; Lioy, P. J. Integrated exposure and dose modeling and analysis system. 1. Formulation and testing of microenvironmental and pharmacokinetic components. Environ. Sci. Technol. 1997, 31, 17-27.
18. Cahill, T. M.; Cousins, I.; Mackay, D. Development and application of a generalized physiologically based pharmacokinetic model for multiple environmental contaminants. Environ. Toxicol. Chem. 2003, 22, 26-34.
19. Leung, H. W. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J. Toxicol. Environ. Health 1991, 32, 247-267.
20. Andersen, M. E.; Gargas, M. L.; Clewell, H. J. D.; Severyn, K. M. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 1987, 89, 149-157.
21. Krishnan, K.; Clewell, H. J.; Andersen, M. E. Physiologically based pharmacokinetic analyses of simple mixtures. Environ. Health Perspect. 1994, 102, 151-155.
22. Guengerich, F. P.; Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 1991, 4, 391-407.
23. USEPA. Proposed guidelines for carcinogen risk assessment; U.S. Environmental Protection Agency: 1996; EPA/600/P-92/003C.
24. Andersen, M. E.; Clewell, H. J., III; Gargas, M. L.; Smith, F. A.; Reitz, R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 1987, 87, 185-205.
25. Clewell, H. J. D.; Andersen, M. E. Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1985, 1, 111-131.
26. Yang, R. S. H.; Dennison, J. E. Method of Analysis to Perform a Tissue-Based Cumulative Risk Assessment for Mixtures of Chemicals. Draft Final Report; A Report to USEPA under Contract No. 3C-R102-NTEX; USEPA National Center for Environmental Assessment: Cincinnati, OH, 2003; pp 1-46.
27. Tardif, R.; Charest-Tardif, G.; Brodeur, J.; Krishnan, K. Physiologically based pharmacokinetic modeling of a ternary mixture of alkyl benzenes in rats and humans. Toxicol. Appl. Pharmacol. 1997, 144, 120-134.
28. Dennison, J. E.; Andersen, M. E.; Yang, R. S. H. Characterization of the pharmacokinetics of gasoline using PBPK modeling with a complex mixtures chemical lumping approach. Inhal. Toxicol. 2003, 15, 961-986.
29. Ancheyta-Juarez, J.; Lopez-Isunza, F.; Aguilar-Rodriguez, E. 5-Lump kinetic model for gas oil catalytic cracking. Appl. Catal. A-Gen. 1999, 177, 227-235.
30. Ancheyta-Juarez, J.; Sotelo-Boyas, R. Estimation of kinetic constants of a five-lump model for fluid catalytic cracking process using simpler sub-models. Energy Fuels 2000, 14, 1226-1231.
31. Harley, R. A.; Russell, A. G.; Cass, G. R. Mathematical modeling of the concentrations of volatile organic compounds: model performance using a lumped chemical mechanism. Environ. Sci. Technol. 1993, 27, 1638-1649.
32. Gargas, M. L.; Andersen, M. E.; Clewell, H. J. D. A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 1986, 86, 341-352.
33. Macey, R. I.; Oster, G. F. 2002. Berkeley Madonna, http://www. berkeleymadonna.com.
34. Ramsey, J. C.; Andersen, M. E. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 1984, 73, 159-175.
35. Segel, I. H. Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme systems; Wiley: New York, 1993; p 105.
36. Brown, R. P.; Delp, M. D.; Lindstedt, S. L.; Rhomberg, L. R.; Beliles, R. P. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 1997, 13, 407-484.
37. Johanson, G.; Filser, J. G. Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Arch. Toxicol. 1992, 66, 291-295.
38. Gargas, M. L.; Burgess, R. J.; Voisard, D. E.; Cason, G. H.; Andersen, M. E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharm. 1989, 98, 87-99.
39. Haddad, S.; Tardif, R.; Charest-Tardif, G.; Krishnan, K. Physiological modeling of the toxicokinetic interactions in a quaternary mixture of aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 1999, 161, 249-257.
40. Clewell, H. J., III. The application of physiologically based pharmacokinetic modeling in human health risk assessment of hazardous substances. Toxicol. Lett. 1995, 79, 207-217.
41. Andersen, M. E.; Clewell, H. J. Pharmacokinetic interactions of mixtures. Proceedings of the 14th Conference on Environmental Toxicology, November 1983, at Dayton, OH. Paper No. 16. 1984.
42. Poulin, P.; Krishnan, K. A mechanistic algorithm for predicting blood: air partition coefficients of organic chemicals with the consideration of reversible binding in hemoglobin. Toxicol. Appl. Pharmacol. 1996, 136, 131-137.
43. Schwarzenbach, R. P.; Gschwend, P. M.; Imboden, D. M. Environmental organic chemistry; Wiley: New York, 1993; p 123.
44. ACGIH. 2003 TLVs and BEIs: Threshold Limit Values for Chemical Substances and Physical Agents; Biological Exposure Indices; American Conference of Governmental Industrial Hygienists: Cincinnati, 2003.
45. Dobrev, I. D.; Andersen, M. E.; Yang, R. S. In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane. Environ. Health Perspect. 2002, 110, 1031-1039.